Suppr超能文献

铂化合物在人体肿瘤中的摄取。体外研究。

Uptake of platinum compounds in human tumors. In vitro study.

作者信息

Hecquet B, Leroy A, Lefebvre J L, Peyrat J P, Adenis L

出版信息

Bull Cancer. 1986;73(5):535-41.

PMID:3535936
Abstract

The kinetics of intratumoral uptake of cisplatin, carboplatin (CBDCA) and TNO-6 were studied in vitro in fragments of tumors of the head and neck maintained in culture medium under conditions simulating therapeutic conditions of chemo-embolization. Cisplatin and TNO-6 are more rapidly taken up than CBDCA (carboplatin). With each of these compounds, after 24 hours a fraction of the platinum taken up is not irreversibly bound to the tissue. The rate of uptake and the proportion of platinum irreversibly bound depends a great deal on the tumor under study. The characteristics of the diffusion indicate that TNO-6 is better used with chemo-embolization than with systemic injection. The opposite finding is seen with carboplatin. Cisplatin appears to to be about equally well-suited for either method of injection.

摘要

在模拟化疗栓塞治疗条件下,将头颈部肿瘤碎片置于培养基中进行体外培养,研究了顺铂、卡铂(CBDCA)和TNO-6在肿瘤内的摄取动力学。顺铂和TNO-6比卡铂(CBDCA)摄取更快。使用这些化合物中的每一种,24小时后摄取的一部分铂并未不可逆地与组织结合。摄取速率和铂不可逆结合的比例在很大程度上取决于所研究的肿瘤。扩散特征表明,TNO-6与化疗栓塞联合使用比全身注射效果更好。卡铂则相反。顺铂似乎同样适合这两种注射方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验